EUVIMEDEUVIMED entdecken
Open Access

Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024

Jordan B Singleton iD, Dennis Wang iD, Souci Louis iD, Dallas J Smith iD, Anastasia S Lambrou iD, Susan E Beekmann iD, Claire M Midgley, Philip Polgreen, Shikha Garg iD, Jessica N Ricaldi, Timothy M Uyeki iD, Scott Santibañez iD und 1 weitere

Open Forum Infectious Diseases · 27.11.2024 · 11 (12)

DOI: 10.1093/ofid/ofae666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 08.11.2024. Verfasst von Jordan B Singleton und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiviral therapy is underutilized for outpatients at increased risk for severe COVID-19 or influenza. Results from this survey offer insights into treatment barriers from the infectious disease specialist perspective. Further education is needed about the benefits of early antiviral therapy.

Schlagwörter

Stichwörter der Autor:innen

COVID-19antiviralsbarriersinfluenzatreatment

Autor:innen und Institutionen

  • Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • University of Iowa Carver College of Medicine, Department of Internal Medicine, Iowa City, Iowa, USA.

ORCID-Profile: Jordan B Singleton, Dennis Wang, Souci Louis, Dallas J Smith, Anastasia S Lambrou, Susan E Beekmann, Shikha Garg, Timothy M Uyeki, Scott Santibañez

Förderung

  • Centers for Disease Control and Prevention

Zitieren

APA

Singleton, J. B., Wang, D., Louis, S., Smith, D. J., Lambrou, A. S., Beekmann, S. E., Midgley, C. M., Polgreen, P., Garg, S., Ricaldi, J. N., Uyeki, T. M., Santibañez, S., & Patel, P. (2024). Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024. Open Forum Infectious Diseases, 11(12). https://doi.org/10.1093/ofid/ofae666

Vancouver

Singleton JB, Wang D, Louis S, Smith DJ, Lambrou AS, Beekmann SE, et al. Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024. Open Forum Infectious Diseases. 2024;11(12). doi:10.1093/ofid/ofae666

BibTeX
@article{Singleton2024,
  author = {Singleton, Jordan B and Wang, Dennis and Louis, Souci and Smith, Dallas J and Lambrou, Anastasia S and Beekmann, Susan E and Midgley, Claire M and Polgreen, Philip and Garg, Shikha and Ricaldi, Jessica N and Uyeki, Timothy M and Santibañez, Scott and Patel, Pragna},
  title = {Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024},
  journal = {Open Forum Infectious Diseases},
  year = {2024},
  volume = {11},
  number = {12},
  doi = {10.1093/ofid/ofae666}
}
Kostenlos starten →